US Bancorp’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-332
| Closed | -$24K | – | 4044 |
|
|
2020
Q4 | $24K | Hold |
332
| – | – | ﹤0.01% | 2848 |
|
|
2020
Q3 | $15K | Sell |
332
-1,155
| -78% | -$48.3K | ﹤0.01% | 2943 |
|
|
2020
Q2 | $67K | Sell |
1,487
-113
| -7% | -$5.06K | ﹤0.01% | 2307 |
|
|
2020
Q1 | $61K | Sell |
1,600
-77
| -5% | -$3.54K | ﹤0.01% | 2274 |
|
|
2019
Q4 | $77K | Sell |
1,677
-271
| -14% | -$11.7K | ﹤0.01% | 2284 |
|
|
2019
Q3 | $79K | Sell |
1,948
-256
| -12% | -$11.1K | ﹤0.01% | 2266 |
|
|
2019
Q2 | $107K | Sell |
2,204
-21
| -0.9% | -$1.1K | ﹤0.01% | 2178 |
|
|
2019
Q1 | $140K | Sell |
2,225
-3,225
| -59% | -$222K | ﹤0.01% | 2011 |
|
|
2018
Q4 | $325K | Sell |
5,450
-4,411
| -45% | -$265K | ﹤0.01% | 1528 |
|
|
2018
Q3 | $636K | Sell |
9,861
-15,555
| -61% | -$868K | ﹤0.01% | 1332 |
|
|
2018
Q2 | $1.14M | Sell |
25,416
-369
| -1% | -$14.7K | ﹤0.01% | 1041 |
|
|
2018
Q1 | $802K | Buy |
25,785
+1,143
| +5% | +$37.6K | ﹤0.01% | 1204 |
|
|
2017
Q4 | $737K | Buy |
24,642
+1,456
| +6% | +$42.2K | ﹤0.01% | 1253 |
|
|
2017
Q3 | $765K | Buy |
23,186
+18,876
| +438% | +$654K | ﹤0.01% | 1217 |
|
|
2017
Q2 | $145K | Buy |
+4,310
| New | +$129K | ﹤0.01% | 2001 |
|
|
2016
Q4 | – | Sell |
-3,795
| Closed | -$70K | – | 3759 |
|
|
2016
Q3 | $70K | Sell |
3,795
-4,080
| -52% | -$76.9K | ﹤0.01% | 2275 |
|
|
2016
Q2 | $128K | Sell |
7,875
-188
| -2% | -$2.77K | ﹤0.01% | 1905 |
|
|
2016
Q1 | $94K | Hold |
8,063
| – | – | ﹤0.01% | 2041 |
|
|
2015
Q4 | $94K | Buy |
+8,063
| New | +$102K | ﹤0.01% | 2108 |
|
|
2014
Q1 | – | Sell |
-22,396
| Closed | -$178K | – | 3652 |
|
|
2013
Q4 | $178K | Sell |
22,396
-500
| -2% | -$4.67K | ﹤0.01% | 1791 |
|
|
2013
Q3 | $227K | Hold |
22,896
| – | – | ﹤0.01% | 1638 |
|
|
2013
Q2 | $135K | Buy |
+22,896
| New | +$77K | ﹤0.01% | 1858 |
|
Other funds holding BEAT
US Bancorp's BEAT Position: Q1 2021 in Review
US Bancorp sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 332 shares — an estimated $24K sold.
US Bancorp first reported a position in BEAT in Q2 2013 and held it in 22 quarters. The position peaked at $1.14M in Q2 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- US Bancorp reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- US Bancorp sold 332 BioTelemetry, Inc. shares in Q1 2021, an estimated $24K.
- US Bancorp first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 22 quarters.
- US Bancorp's BioTelemetry, Inc. position peaked at $1.14M in Q2 2018.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on US Bancorp's 13F filing for Q1 2021, filed 28 Apr 2021.